Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05732779 · ClinicalTrials.gov registry record · NA
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
A NA study of Health Behavior and Patient Engagement, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 4
- Study locations
NCT05732779: Recruiting NA study of Health Behavior and Patient Engagement, sponsored by University of Florida.
NCT05732779 is a NA study of Health Behavior and Patient Engagement that is actively recruiting participants, run by University of Florida. The registered enrollment target is 100 participants, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05732779, a NA study of Health Behavior and Patient Engagement, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
We will conduct a two-group randomized controlled trial to examine the eMocha DOT intervention with pediatric HT recipients.In this population, medication nonadherence remains a primary cause of late acute rejection (LAR) episodes, increased number of hospitalizations, graft failure, and patient mortality. Herein, we propose an innovative approach to promote medication adherence and improve patient and graft outcomes.
Primary Outcome
medication level variability index (MLVI). MLVI is calculated as the Standard Deviation of a set of at least 3 tacrolimus trough blood levels for each participant.
Conditions Studied
Interventions
- OTHER DOT intervention
Study Locations (4)
Florida
- University of Miami, Miller School of Medicine - Coral Gables
- University of Florida - Gainesville
- Joe DiMaggio Children's Hospital - Hollywood
- FSU College of Medicine - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What NCT05732779 shows while recruiting
NCT05732779 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower).
The record links to 7 conditions, with Health Behavior appearing as the primary indexed condition, and to 1 intervention - of which DOT intervention is the first listed.
NCT05732779 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05732779 about?
NCT05732779 is a clinical study titled "Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients". We will conduct a two-group randomized controlled trial to examine the eMocha DOT intervention with pediatric HT recipients.In this population, medication nonadherence remains a primary cause of late acute rejection (LAR) episodes, increased number of hospitalizations, graft failure, and patient mor...
What is the current status of trial NCT05732779?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-01. Estimated completion is 2027-05-01.
What conditions does trial NCT05732779 study?
This clinical trial studies the following conditions: Health Behavior, Patient Engagement, Heart Transplant Rejection, Medication Non Adherence, Immune Suppression.
What interventions are being tested in trial NCT05732779?
The interventions under investigation include: DOT intervention (OTHER).
Who is sponsoring clinical trial NCT05732779?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05732779 being conducted?
This trial has 4 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05732779's enrollment target sits among peer trials
100 41st of 65 higher than 20 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Validation Study of Bioelectronics
RECRUITING · NA
-
A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
RECRUITING · NA
-
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI